Abivax (AAVXF) EPS (Basic) (2022 - 2026)
Abivax (AAVXF) posted EPS (Basic) of -$0.81 for Q1 2026, up 31.28% on a QoQ basis from -$1.18 in Q4 2025, and up 7.47% year-over-year from -$0.75 in Q1 2025.
Powered by 
Analysis
Abivax (AAVXF) EPS (Basic) (2022 - 2026) Analysis & Trends
Abivax has reported EPS (Basic) for 5 years, with the latest figure at -$0.81 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 7.47% year-over-year to -$0.81 in Q1 2026; TTM through Mar 2026 was -$5.35, a 69.07% decrease from a year earlier, with the FY2025 full-year figure at -$5.43, down 81.82% from the prior year.
- EPS (Basic) was -$0.81 for Q1 2026 at Abivax, up from -$1.18 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.67 in Q4 2024, with the low at -$3.46 in Q4 2022.
- Average EPS (Basic) over 5 years is -$1.58, with a median of -$1.08 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) jumped 79.03% in 2024, then slumped 101.92% in 2025.
- Over 5 years, EPS (Basic) stood at -$3.46 in 2022, then gained by 8.08% to -$3.18 in 2023, then surged by 79.03% to -$0.67 in 2024, then plunged by 76.25% to -$1.18 in 2025, then jumped by 31.28% to -$0.81 in 2026.
- The last three EPS (Basic) figures came in at -$0.81 (Q1 2026), -$1.18 (Q4 2025), and -$2.84 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | -0.40 |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | -0.81 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -1.18 |
| Sep 30, 2025 | -2.84 |
| Jun 30, 2025 | -0.87 |
| Mar 31, 2025 | -0.87 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -0.97 |
| Mar 31, 2024 | -1.08 |
| Dec 31, 2023 | -3.18 |
| Dec 31, 2022 | -3.46 |